TriSalus Life Sciences Warrant
TLSIW
29 hedge funds and large institutions have $2.55M invested in TriSalus Life Sciences Warrant in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.
3% less funds holding
Funds holding: 30 → 29 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
66% less capital invested
Capital invested by funds: $7.44M → $2.55M (-$4.89M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
AGM
Alpine Global Management
New York
|
+$829 |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$43 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
26
Old Mission Capital
Chicago,
Illinois
| $1K | +$43 | +595 | +6% |
|
|
AGM
27
Alpine Global Management
New York
| $1K | +$829 | +11,600 | New |
|
|
MP
28
Mangrove Partners
Greenwich,
Connecticut
| – | -$4.92M | -500,000 | Closed |
|
|
MC
29
Meteora Capital
Boca Raton,
Florida
| – | -$1K | -17,094 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$1 | -10 | -0.2% |
|
TLSIW Hedge Fund Activity: Q3 2022 in Review
29 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q3 2022, worth a combined $2.55M — down 66% from $7.44M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TLSIW and 1 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Alpine Global Management, opening a new position worth an estimated $829. The largest seller was Mangrove Partners, exiting entirely with an estimated $4.92M sold.
- 29 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q3 2022, down from 30 in Q2 2022.
- Funds reported $2.55M of TriSalus Life Sciences Warrant stock for Q3 2022, down 66% quarter-over-quarter.
- 1 fund opened new TriSalus Life Sciences Warrant positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest TriSalus Life Sciences Warrant buyer in Q3 2022 was Alpine Global Management, an estimated $829 added.
- The largest TriSalus Life Sciences Warrant seller in Q3 2022 was Mangrove Partners, an estimated $4.92M sold.
Based on aggregated 13F filings for Q3 2022.